CARs on track in the clinic
- PMID: 21358705
- PMCID: PMC3048197
- DOI: 10.1038/mt.2011.1
CARs on track in the clinic
Similar articles
-
Gene-modified hematopoietic stem cells for cancer immunotherapy.Hum Vaccin Immunother. 2014;10(4):982-5. doi: 10.4161/hv.27637. Epub 2014 Jan 9. Hum Vaccin Immunother. 2014. PMID: 24398603 Free PMC article.
-
Immunotherapy with chimeric antigen receptors for multiple myeloma.Discov Med. 2014 Jan;17(91):37-46. Discov Med. 2014. PMID: 24411699 Review.
-
Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.Hum Gene Ther. 2013 Oct;24(10):824-39. doi: 10.1089/hum.2012.202. Hum Gene Ther. 2013. PMID: 23978226 Free PMC article.
-
Do CARs need a driver's license? Adoptive cell therapy with chimeric antigen receptor-redirected T cells has caused serious adverse events.Hum Gene Ther. 2010 Sep;21(9):1039-42. doi: 10.1089/hum.2010.131. Hum Gene Ther. 2010. PMID: 20626322 No abstract available.
-
Antibody-modified T cells: CARs take the front seat for hematologic malignancies.Blood. 2014 Apr 24;123(17):2625-35. doi: 10.1182/blood-2013-11-492231. Epub 2014 Feb 27. Blood. 2014. PMID: 24578504 Free PMC article. Review.
Cited by
-
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.Hum Gene Ther. 2012 May;23(5):444-50. doi: 10.1089/hum.2011.167. Epub 2012 Jan 17. Hum Gene Ther. 2012. PMID: 22107246 Free PMC article. Clinical Trial.
-
Profile of ipilimumab and its role in the treatment of metastatic melanoma.Drug Des Devel Ther. 2011;5:489-95. doi: 10.2147/DDDT.S10945. Epub 2011 Dec 16. Drug Des Devel Ther. 2011. PMID: 22267918 Free PMC article. Review.
-
In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33 Acute Myeloid Leukemia.Adv Hematol. 2012;2012:683065. doi: 10.1155/2012/683065. Epub 2012 Jan 5. Adv Hematol. 2012. PMID: 22272203 Free PMC article.
-
Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells.Cancer Immunol Res. 2015 Apr;3(4):356-67. doi: 10.1158/2326-6066.CIR-14-0186. Epub 2015 Jan 19. Cancer Immunol Res. 2015. PMID: 25600436 Free PMC article.
-
Genetically modified T cells for the treatment of malignant disease.Transfus Med Hemother. 2013 Dec;40(6):388-402. doi: 10.1159/000357163. Epub 2013 Nov 29. Transfus Med Hemother. 2013. PMID: 24474888 Free PMC article. Review.
References
-
- Bridgeman JS, Hawkins RE, Hombach AA, Abken H., and, Gilham DE. Building better chimeric antigen receptors for adoptive T cell therapy. Curr Gene Ther. 2010;10:77–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources